by Ernest Beutler Blood Volume 98(9): November 1, 2001

Slides:

Advertisements

Similar presentations

JAK2V617F mutation for the early diagnosis of Ph − myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis by Francesco Dentali,

Advertisements

© 2014 Direct One Communications, Inc. All rights reserved. 1 Genetics of Hemophilia: The Role of Genetic Testing and the Use of Genetics to Guide Treatment.

RNA interference in biology and disease by Carol A. Sledz, and Bryan R. G. Williams Blood Volume 106(3): August 1, 2005 ©2005 by American Society.

Connexin Mutations in Skin Disease and Hearing Loss David P. Kelsell, Wei-Li Di, Mark J. Houseman The American Journal of Human Genetics Volume 68, Issue.

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.

Maple Syrup Urine Disease: Identification and Carrier-Frequency Determination of a Novel Founder Mutation in the Ashkenazi Jewish Population Lisa Edelmann,

Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease by Marilyn J. Telen Blood Volume 127(7): February 18, 2016 ©2016 by.

Genes and Variation Genotypes and phenotypes in evolution Natural selection acts on phenotypes and does not directly on genes. Natural selection.

How I treat HHV8/KSHV-related diseases in posttransplant patients by Giovanni Riva, Mario Luppi, Patrizia Barozzi, Fabio Forghieri, and Leonardo Potenza.

Peopling of Sahul: mtDNA Variation in Aboriginal Australian and Papua New Guinean Populations Alan J. Redd, Mark Stoneking The American Journal of Human.

Phenotypic and Functional Changes Induced at the Clonal Level in Hematopoietic Stem Cells After 5-Fluorouracil Treatment by Troy D. Randall, and Irving.

Montgomery Slatkin The American Journal of Human Genetics

CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence by Fiorina Giona, Luciana Teofili, Sara Capodimonti, Marica.

by Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E

VEGF therapy: risky business for established plaques?

“Vitamin hypothesis”: explanation for allergy increase?

by Toru Takahashi, Toshiaki Yujiri, and Yukio Tanizawa

by Henrik Frederiksen, and Kai Schmidt

Minimal Residual Disease Measurement By Deep Sequencing Reflects Changes In Disease Load During Therapy In Diffuse Large B Cell Lymphoma Patients by Nina.

by Timothy P. Hughes, and David M. Ross

by James O. Armitage, and Dan L. Longo

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population by Daniel B. Bellissimo,

Gupta V, Tallman MS, Weisdorf DJ

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

by Nataliya Melnyk, and Jonathan Harrison

A cell by any other name by Narla Mohandas Blood

Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy by Chun.

How I treat elderly patients with myeloma

Rapid Identification Of Compound Mutations In Patients With Ph-Positive Leukemias By Long-Range Next Generation Sequencing by Sandra Preuner, Renate Kastner,

Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)‏ by Charlotte Louise Godfrey,

Critiquing Cryos by Morie Gertz Blood Volume 111(11):

Nonmyeloablative conditioning for relapsed follicular lymphoma

Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated With Mortality In Patients With Prostate Cancer by Shruti Chaturvedi, Surbhi.

Rebuttal to Ajioka and Kushner

V617F “JAKs” up myeloproliferative signal

Topical Sodium Nitrite Is Effective In Reducing Leg Ulcer-Associated Pain In Patients With Sickle Cell Disease by Caterina P. Minniti, Caroline Cantilena,

Autologous Transplantation Therapy for Chronic Myelogenous Leukemia

A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease by Sten Myrehaug, Melania Pintilie, Lingsong.

An Unusual Cause of Abdominal Pain in Sickle Cell Disease

Genetic sequence analysis of inherited bleeding diseases

Serum Levels of Substance P Are Elevated in Patients With Sickle Cell Disease and Increase Further During Vaso-Occlusive Crisis by Lisa A. Michaels, Kwaku.

Relationship of p53, bcl-2, and Tumor Proliferation to Clinical Drug Resistance in Non-Hodgkin's Lymphomas by Wyndham H. Wilson, Julie Teruya-Feldstein,

Protease inhibitors potentiate chemotherapy-induced neutropenia

Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein.

Red cell adenylate kinase deficiency: molecular study of 3 new mutations (118G>A, 190G>A, and GAC deletion) associated with hereditary nonspherocytic hemolytic.

by Alexander Röth, Andreas Hüttmann, Russell P

An actuarial GPS for hemophilic longevity

VWF sequence variants: innocent until proven guilty

by Sabah Sallah, and Jim Y. Wan

by Jayesh Mehta Blood Volume 112(2): July 15, 2008

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Stage C or not stage C…? by Claire Dearden Blood

Total-Thrombus-Formation Analysis System Using a Microchip Flow Chamber Reflects Bleeding Severity of Patients with Type 1 Von Willebrand Disease. by Kenichi.

Incidence and Predictors Of Venous Thromboembolism Among Lymphoma Patients In Denmark: A Nationwide Population-Based Cohort Study by Jennifer L Lund, Lene.

by John J. Strouse, Megan E. Reller, David G

Montgomery Slatkin The American Journal of Human Genetics

Activity of eltrombopag in severe aplastic anemia

Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma by Young Ae Kim, Ja Min Byun, Keeho Park, Gi Hwan Bae, Dukhyoung.

by Santosh L. Saraf, Xu Zhang, Tamir Kanias, James P. Lash, Robert E

Predicted number of joint bleeds according to factor activity level and age group for patients with hemophilia A or B based on a regression model. Predicted.

Volume 2(Supplement 1):46-49

Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry by Donald M. Arnold, Ishac Nazy, Rumi.

Mammen Chandy Biology of Blood and Marrow Transplantation

Overcoming “aspirin resistance” in MPN

Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.

Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.

Pure red cell aplasia by Robert T. Means Blood

by Chatree Chai-Adisaksopha, Davide Matino, and Alfonso Iorio

Overall survival of systemic mastocytosis patients.

Cold agglutinin disease

Presentation transcript:

Discrepancies between genotype and phenotype in hematology: an important frontier by Ernest Beutler Blood Volume 98(9):2597-2602 November 1, 2001 ©2001 by American Society of Hematology

Relation between disease severity and age in patients with two genotypes of Gaucher disease. Relation between disease severity and age in patients with two genotypes of Gaucher disease. The 1226G (N370S) mutation is a mild mutation common in the Jewish population. The frameshift 84GG is a null mutation. Variation within each genotype is great, and there is marked overlap among the phenotypes of patients with these two genotypes. Ernest Beutler Blood 2001;98:2597-2602 ©2001 by American Society of Hematology